Global Health Shake-up: From IPOs to Apologies
Published on: Aug. 29, 2025, 2:31 a.m. | Source: Devdiscourse
The health sector sees significant developments: Stada revives IPO plans, US CDC faces resignations over vaccine policy changes, BioXcel seeks at-home drug approval, African nations face food shortages, Amylyx halts brain disorder drug trials, GSK and Teva secure key approvals, and Denmark apologizes for past birth control policies in Greenland.
